Non-invasive biomarkers and scoring systems show strong capability in differentiating chronic liver disease from cirrhosis, ...

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...

According to an expert panel report, as against 14026 cases of alcohol-related liver ailments in 2014-19, the number ...

According to an expert panel report, as against 14026 cases of alcohol-related liver ailments in 2014-19, the number ...

The three-member panel formed by Chief Minister N Chandrababu Naidu analysed health data from Arogyasri, a flagship scheme ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Approximately 850 people underwent free liver scans this week at the RAI Amsterdam convention center, where the European ...

To test their new drug, the researchers conducted experiments on mice that were fed a high-fat diet, which typically leads to ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Distinct trends were seen in etiology-based mortality with chronic liver disease (CLD) before, during, and after the COVID-19 ...

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...